BTC logo
BTC
$105,240.77
5.13%
ETH logo
ETH
$3,752.51
7.16%
USDT logo
USDT
$1.0004
0.03%
BNB logo
BNB
$1,057.31
10.24%
XRP logo
XRP
$2.2657
6.48%
SOL logo
SOL
$178.53
8.62%
USDC logo
USDC
$1.0001
0.01%
TRX logo
TRX
$0.3059
5.23%
DOGE logo
DOGE
$0.1818
7.51%
ADA logo
ADA
$0.6148
8.68%
USDE logo
USDE
$0.9995
0.06%
HYPE logo
HYPE
$34.36
10.09%
LINK logo
LINK
$16.33
10.63%
XLM logo
XLM
$0.3001
8.31%
BCH logo
BCH
$459.85
12.07%
LEO logo
LEO
$9.4212
2.27%
WBT logo
WBT
$40.15
4.56%
SUI logo
SUI
$2.3784
11.22%
AVAX logo
AVAX
$19.62
10.66%
HBAR logo
HBAR
$0.1605
11.40%
BTC logo
BTC
$105,240.77
5.13%
ETH logo
ETH
$3,752.51
7.16%
USDT logo
USDT
$1.0004
0.03%
BNB logo
BNB
$1,057.31
10.24%
XRP logo
XRP
$2.2657
6.48%
SOL logo
SOL
$178.53
8.62%
USDC logo
USDC
$1.0001
0.01%
TRX logo
TRX
$0.3059
5.23%
DOGE logo
DOGE
$0.1818
7.51%
ADA logo
ADA
$0.6148
8.68%
USDE logo
USDE
$0.9995
0.06%
HYPE logo
HYPE
$34.36
10.09%
LINK logo
LINK
$16.33
10.63%
XLM logo
XLM
$0.3001
8.31%
BCH logo
BCH
$459.85
12.07%
LEO logo
LEO
$9.4212
2.27%
WBT logo
WBT
$40.15
4.56%
SUI logo
SUI
$2.3784
11.22%
AVAX logo
AVAX
$19.62
10.66%
HBAR logo
HBAR
$0.1605
11.40%
Layer2
Share this article

A DAO for Diseases: How Vibe Bio Plans to Retool Biotech Funding

Vibe Bio’s founder wasn’t passionate about creating a DAO – but decentralizing drug research could fix a thorny, tragic problem.

By David Z. Morris
Updated May 11, 2023, 6:10 p.m. Published Jul 15, 2022, 5:11 p.m.
Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)
Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)